
Public Firm Sonnet BioTherapeutics to Launch HyperLiquid Treasury in New Deal
Sonnet BioTherapeutics, Inc. has agreed to merge with Rorschach I LLC to become Hyperliquid Strategies in a deal worth $888 million.
1H
-1.26%$0.6027
24H
-3.25%$1.59
7D
24.7%$9.36
30D
16.7%$6.75
Sonnet BioTherapeutics, Inc. has agreed to merge with Rorschach I LLC to become Hyperliquid Strategies in a deal worth $888 million.
Hyperliquid has surpassed $1.57 trillion in perpetual futures trading volume over the past year, while its HYPE token continues its bullish trajectory.
Hyperliquid (HYPE) has seen strong selling pressure, correcting nearly 20% from its $45 all-time high, and dropping below $38 in the last 24 hours.
Hyperliquid (HYPE) has outpaced the broader crypto market with 12% gains, as influencers take massive BTC, ETH leveraged bets on the DEX.
Hyperliquid price has gained 9.82%, reaching $36.23, following Binance.US’s announcement of an upcoming spot listing.
Let us introduce you to TrueUSD – stablecoin that is highly appreciated for its transparency and that has grown to become the most preferred choice of many traders.
Looking to monetize your crypto audience? Discover the 10 best crypto affiliate programs in 2025 with top-tier commissions, lifetime payouts, and tools for maximized conversions.